Literature DB >> 8040068

Fusarium merismoides Corda NR 6356, the source of the protein kinase C inhibitor, azepinostatin. Taxonomy, yield improvement, fermentation and biological activity.

S Ohshima1, M Yanagisawa, A Katoh, T Fujii, T Sano, S Matsukuma, T Furumai, M Fujiu, K Watanabe, K Yokose.   

Abstract

Fungal strain NR 6356, Fusarium merismoides Corda, was discovered as the source of the protein kinase C (PKC) inhibitor, azepinostatin. The strain was identified based on its growth on potato sucrose agar, slender conidial shape, characteristic polyphialide and production of abundant chlamydospores. Fusarium aquaeductuum Lagh. IMI 103658 and Fusarium sp. NR 7222 were also found to produce the same inhibitor. After single colony isolation and medium optimization trials, a more than 30-fold increase in the production of azepinostatin over the original culture was achieved. Azepinostatin selectively and potently inhibited rat brain PKC with an IC50 value of 70 nM. Other enzymes utilizing ATP, including hexokinase, were not affected. The Ki of azepinostatin for PKC was 0.5 nM. The inhibition of PKC was competitive with ATP and uncompetitive with histone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040068     DOI: 10.7164/antibiotics.47.639

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Gram-Level Production of Balanol through Regulatory Pathway and Medium Optimization in Herb Fungus Tolypocladium ophioglossoides.

Authors:  Rui-Qi Li; Xiang Liu; Min Zhang; Wei-Qun Xu; Yong-Quan Li; Xin-Ai Chen
Journal:  J Fungi (Basel)       Date:  2022-05-16

2.  A unified approach to the important protein kinase inhibitor balanol and a proposed analogue.

Authors:  Tapan Saha; Ratnava Maitra; Shital K Chattopadhyay
Journal:  Beilstein J Org Chem       Date:  2013-12-19       Impact factor: 2.883

Review 3.  Application of asymmetric Sharpless aminohydroxylation in total synthesis of natural products and some synthetic complex bio-active molecules.

Authors:  Majid M Heravi; Tahmineh Baie Lashaki; Bahareh Fattahi; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2018-02-09       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.